{"id":"https://openalex.org/W2000807287","doi":"https://doi.org/10.1097/01.ju.0000169481.42259.54","title":"DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITY","display_name":"DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITY","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-09","ids":{"openalex":"https://openalex.org/W2000807287","doi":"https://doi.org/10.1097/01.ju.0000169481.42259.54","mag":"2000807287","pmid":"https://pubmed.ncbi.nlm.nih.gov/16094018"},"language":"en","primary_location":{"id":"doi:10.1097/01.ju.0000169481.42259.54","doi":"https://doi.org/10.1097/01.ju.0000169481.42259.54","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000169481.42259.54","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000807287"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018327929","display_name":"Apostolos Apostolidis","orcid":"https://orcid.org/0000-0003-4694-0578","observed_orcids":["https://orcid.org/0000-0003-4694-0578"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. APOSTOLIDIS","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019507506","display_name":"Roshni Popat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. POPAT","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049755012","display_name":"Y. Yiangou","orcid":"https://orcid.org/0000-0003-3518-5474","observed_orcids":["https://orcid.org/0000-0003-3518-5474"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Y. YIANGOU","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029575711","display_name":"Debra A. Cockayne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. COCKAYNE","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065067986","display_name":"Anthony P.D.W. Ford","orcid":"https://orcid.org/0000-0001-8618-0273","observed_orcids":["https://orcid.org/0000-0001-8618-0273"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A.P.D.W. FORD","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J.B. DAVIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.B. DAVIS","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006241226","display_name":"Prokar Dasgupta A","orcid":"https://orcid.org/0000-0001-8690-0445","observed_orcids":["https://orcid.org/0000-0001-8690-0445"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. DASGUPTA","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111933125","display_name":"Clare J. Fowler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C.J. FOWLER","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069664472","display_name":"Praveen Anand","orcid":"https://orcid.org/0000-0002-2478-7042","observed_orcids":["https://orcid.org/0000-0002-2478-7042"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. ANAND","raw_affiliation_strings":["From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Peripheral Neuropathy Unit, Hammersmith Hospital, Imperial College London (AA, YY, PA), Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, University College London Hospital (AA, RP, PD, CJF), and Department of Urology, Guy\u2019s and St. Thomas\u2019 Hospitals (PD), London, the Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow (JBD), United Kingdom, and the Neurobiology Unit, Roche Palo Alto, Palo Alto, California (DC, APDWF)","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I4210151618","https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":30.9576,"has_fulltext":false,"cited_by_count":540,"citation_normalized_percentile":{"value":0.99890591,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"174","issue":"3","first_page":"977","last_page":"983"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/botulinum-toxin-type-a","display_name":"botulinum toxin type A","score":0.9549999833106995},{"id":"https://openalex.org/keywords/detrusor-overactivity","display_name":"detrusor overactivity","score":0.9950000047683716},{"id":"https://openalex.org/keywords/p2x3-receptor","display_name":"P2X3 receptor","score":0.8059999942779541},{"id":"https://openalex.org/keywords/trpv1","display_name":"TRPV1","score":1.0},{"id":"https://openalex.org/keywords/neurogenic-detrusor-overactivity","display_name":"neurogenic detrusor overactivity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/idiopathic-detrusor-overactivity","display_name":"idiopathic detrusor overactivity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/urgency","display_name":"urgency","score":0.5569999814033508},{"id":"https://openalex.org/keywords/urothelium","display_name":"urothelium","score":0.6259999871253967},{"id":"https://openalex.org/keywords/pgp-9-5","display_name":"PGP 9.5","score":0.7080000042915344},{"id":"https://openalex.org/keywords/intradetrusor-injection","display_name":"intradetrusor injection","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C160145004","wikidata":"https://www.wikidata.org/wiki/Q413209","display_name":"TRPV1","level":4,"score":0.7504860162734985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7256770730018616},{"id":"https://openalex.org/C94487597","wikidata":"https://www.wikidata.org/wiki/Q11101","display_name":"Sensory system","level":2,"score":0.5581061244010925},{"id":"https://openalex.org/C2777478456","wikidata":"https://www.wikidata.org/wiki/Q208413","display_name":"Botulinum toxin","level":2,"score":0.5467414855957031},{"id":"https://openalex.org/C2780616540","wikidata":"https://www.wikidata.org/wiki/Q568055","display_name":"Detrusor muscle","level":3,"score":0.5290920734405518},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.47812071442604065},{"id":"https://openalex.org/C2775907655","wikidata":"https://www.wikidata.org/wiki/Q2635510","display_name":"Sensory nerve","level":3,"score":0.4636572003364563},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.45222172141075134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4494277834892273},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.4245333671569824},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40195372700691223},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3562336266040802},{"id":"https://openalex.org/C2779762690","wikidata":"https://www.wikidata.org/wiki/Q9382","display_name":"Urinary bladder","level":2,"score":0.31030362844467163},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.24426984786987305},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.1836635172367096},{"id":"https://openalex.org/C155164980","wikidata":"https://www.wikidata.org/wiki/Q304043","display_name":"Transient receptor potential channel","level":3,"score":0.09561404585838318},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0932212769985199},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000344","descriptor_name":"Afferent Pathways","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001706","descriptor_name":"Biopsy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000294","qualifier_name":"innervation","is_major_topic":true},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001750","descriptor_name":"Urinary Bladder, Neurogenic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001750","descriptor_name":"Urinary Bladder, Neurogenic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003558","descriptor_name":"Cystoscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007473","descriptor_name":"Ion Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009122","descriptor_name":"Muscle Hypertonia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009122","descriptor_name":"Muscle Hypertonia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009412","descriptor_name":"Nerve Fibers","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009412","descriptor_name":"Nerve Fibers","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009465","descriptor_name":"Neuromuscular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009465","descriptor_name":"Neuromuscular Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011984","descriptor_name":"Sensory Receptor Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014549","descriptor_name":"Urinary Incontinence","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014549","descriptor_name":"Urinary Incontinence","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014563","descriptor_name":"Urodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018048","descriptor_name":"Receptors, Purinergic P2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019459","descriptor_name":"Urothelium","qualifier_ui":"Q000294","qualifier_name":"innervation","is_major_topic":false},{"descriptor_ui":"D019459","descriptor_name":"Urothelium","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D036421","descriptor_name":"Nerve Fibers, Unmyelinated","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D036421","descriptor_name":"Nerve Fibers, Unmyelinated","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D050916","descriptor_name":"TRPV Cation Channels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058477","descriptor_name":"Receptors, Purinergic P2X3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/01.ju.0000169481.42259.54","doi":"https://doi.org/10.1097/01.ju.0000169481.42259.54","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000169481.42259.54","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},{"id":"pmid:16094018","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16094018","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of urology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:104112","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/104112/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J UROLOGY , 174 (3) 977 - 982. (2005)","raw_type":"Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/2bda9003-62fa-4474-b7bb-0cac1b434ebc","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/2bda9003-62fa-4474-b7bb-0cac1b434ebc","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Apostolidis, A, Popat, R, Yiangou, Y, Cockayne, D, Ford, A P D W, Davis, J B, Dasgupta, P, Fowler, C J & Anand, P 2005, 'Decreased sensory receptors P2X(3) and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity', Journal of Urology, vol. 174, no. 3, pp. 977 - 982. https://doi.org/10.1097/01.ju.0000169481.42259.54","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320084","display_name":"Multiple Sclerosis Society","ror":"https://ror.org/043fwdk81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1623121663","https://openalex.org/W1965836027","https://openalex.org/W1971566600","https://openalex.org/W1980021607","https://openalex.org/W1983252944","https://openalex.org/W1987667249","https://openalex.org/W1989319717","https://openalex.org/W2009656267","https://openalex.org/W2019838484","https://openalex.org/W2021815265","https://openalex.org/W2031151714","https://openalex.org/W2039524351","https://openalex.org/W2041762145","https://openalex.org/W2051448097","https://openalex.org/W2055604814","https://openalex.org/W2071297569","https://openalex.org/W2073224536","https://openalex.org/W2089363276","https://openalex.org/W2098776203","https://openalex.org/W2113959251","https://openalex.org/W2159270533","https://openalex.org/W2167481964","https://openalex.org/W4256631357"],"related_works":["https://openalex.org/W2062168648","https://openalex.org/W2076818171","https://openalex.org/W1509296139","https://openalex.org/W7032996357","https://openalex.org/W2791894988","https://openalex.org/W2149011056","https://openalex.org/W2981965744","https://openalex.org/W1562192869","https://openalex.org/W2038600258"],"abstract_inverted_index":{"PURPOSE:":[0],"Botulinum":[1],"neurotoxin":[2],"type":[3],"A":[4,73],"(BoNT/A)":[5],"is":[6,32],"effective":[7],"in":[8,61,123,158,247],"the":[9,55,119,242],"treatment":[10,209],"of":[11,26,46,75,171,233,245],"intractable":[12,87],"detrusor":[13,194,248],"overactivity":[14],"(DO).":[15],"In":[16],"addition":[17],"to":[18,241],"its":[19],"known":[20],"inhibitory":[21],"effect":[22,45,244],"on":[23,48],"presynaptic":[24],"release":[25],"acetylcholine":[27],"by":[28,53],"motor":[29],"terminals,":[30],"there":[31],"increasing":[33],"evidence":[34],"that":[35],"BoNT/A":[36,47,246],"may":[37,239],"affect":[38],"sensory":[39,56,234],"fibers.":[40],"We":[41],"investigated":[42],"a":[43,200],"possible":[44],"human":[49],"bladder":[50,95],"afferent":[51],"mechanisms":[52],"studying":[54],"receptors":[57,235],"P2X3":[58,236],"and":[59,94,101,105,118,129,140,150,160,176,183,214,218,225],"TRPV1":[60,117,238],"biopsies":[62,96],"from":[63],"patients":[64,77],"with":[65,79,83,86,91,125,169],"neurogenic":[66,80],"or":[67,193],"idiopathic":[68,84],"DO.":[69],"MATERIALS":[70],"AND":[71],"METHODS:":[72],"total":[74],"38":[76],"(22":[78],"DO,":[81],"16":[82,102,144,177,186,219],"DO)":[85],"DO":[88],"were":[89,97,108,112,133,156],"treated":[90],"intradetrusor":[92],"BoNT/A,":[93,139],"taken":[98],"at":[99,135,143,174,180,185,210,216],"4":[100,136,175,181,217],"weeks.":[103],"Urodynamics":[104],"voiding":[106],"diary":[107],"also":[109,227],"recorded.":[110],"Specimens":[111],"studied":[113],"immunohistochemically":[114],"for":[115],"P2X3,":[116],"pan-neuronal":[120],"marker":[121],"PGP9.5,":[122],"comparison":[124],"controls.":[126],"RESULTS:":[127],"P2X3-immunoreactive":[128],"TRPV1-immunoreactive":[130],"(-IR)":[131],"fibers":[132,205],"decreased":[134],"weeks":[137,145,178,182],"after":[138,208],"more":[141],"significantly":[142,167],"(paired":[146],"t":[147],"test":[148],"p=0.0004":[149],"p=0.0008,":[151],"respectively),":[152],"when":[153],"significant":[154],"improvements":[155],"observed":[157],"clinical":[159,243],"urodynamic":[161],"parameters.":[162],"P2X3-IR":[163,224],"fiber":[164,197],"decrease":[165,198],"was":[166],"correlated":[168],"reduction":[170],"urgency":[172],"episodes":[173],"(p=0.0013":[179],"p=0.02":[184],"weeks),":[187],"but":[188],"not":[189],"maximum":[190],"cystometric":[191],"capacity":[192],"pressures.":[195],"TRPV1-IR":[196,226],"showed":[199],"similar":[201],"trend.":[202],"PGP9.5-IR":[203],"suburothelial":[204],"remained":[206],"unchanged":[207],"both":[211],"followups":[212],"(p=0.85":[213],"p=0.21":[215],"weeks,":[220],"respectively).":[221],"Urothelial":[222],"cell":[223],"appeared":[228],"unchanged.":[229],"CONCLUSIONS:":[230],"Decreased":[231],"levels":[232],"and/or":[237],"contribute":[240],"overactivity.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000807287","counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":29},{"year":2014,"cited_by_count":32},{"year":2013,"cited_by_count":26},{"year":2012,"cited_by_count":38}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
